home / stock / irraf / irraf quote
Last: | $0.6262 |
---|---|
Change Percent: | 0.0% |
Open: | $0.6262 |
Close: | $0.6262 |
High: | $0.6262 |
Low: | $0.6262 |
Volume: | 18,171 |
Last Trade Date Time: | 06/14/2021 04:41:36 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6262 | $0.6262 | $0.6262 | $0.6262 | $0.6262 | 18,171 | 06-14-2021 |
$0.739 | $0.739 | $0.739 | $0.739 | $0.739 | 14,859 | 09-24-2020 |
$0.7329 | $0.7329 | $0.7329 | $0.7329 | $0.7329 | 5,141 | 09-22-2020 |
$0.7276 | $0.7276 | $0.7276 | $0.7276 | $0.7276 | 200 | 05-06-2020 |
$0.7396 | $0.7396 | $0.7396 | $0.7396 | $0.7396 | 200 | 04-29-2020 |
News, Short Squeeze, Breakout and More Instantly...
Irras AB Company Name:
IRRAF Stock Symbol:
OTCMKTS Market:
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage - IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science - Publi...
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow - The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and ass...
IRRAS to Present at Redeye PR Newswire STOCKHOLM , March 23, 2021 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at th...